Osteotech, Inc. Product Pipeline Analysis

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	44
ISBN Number	not applicable
Product Code	GMD04641

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Osteotech, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reason to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook - Orthopedic Devices
3 Osteotech, Inc. Pipeline Products
- 3.1 Osteotech, Inc. Product Pipeline Analysis
  - 3.1.1 Osteotech, Inc. Pipeline Products By Equipment Type
  - 3.1.2 Osteotech, Inc. Pipeline Products By Development Stage
  - 3.1.3 Osteotech, Inc. Pipeline Products By Therapy Area
  - 3.1.4 Osteotech, Inc. Pipeline Products By News Summary
- 3.2 Osteo-biologic Material
  - 3.2.1 Product Description
  - 3.2.2 Product Status
- 3.3 Spinal Tension Band
  - 3.3.1 Product Description
  - 3.3.2 Product Status
- 3.4 DuraTech
  - 3.4.1 Product Description
  - 3.4.2 Product Status
- 3.5 Plexur M Biocomposite
  - 3.5.1 Product Description
  - 3.5.2 Product Status
  - 3.5.3 Product Milestone
- 3.6 Next Generation DBM
  - 3.6.1 Product Description
  - 3.6.2 Product Status
  - 3.6.3 Product Patent Details
4 Business Description
- 4.1 Business Overview
- 4.2 Major Products and Services
  - 4.2.1 Overview
5 History
6 Competitors
7 Key Employees
8 Key Employee Biographies
9 Company Statement
10 Locations And Subsidiaries
- 10.1 Head Office
11 Financial Deals Landscape
- 11.1 Acquisition
  - 11.1.1 Musculoskeletal Transplant Terminates Its Proposal To Acquire Osteotech
- 11.2 IPO
  - 11.2.1 Osteotech Completes $17.5 Million Private Placement
- 11.3 Partnership
  - 11.3.1 Osteotech Signs Distribution Agreement With Biohorizons
  - 11.3.2 Osteotech Signs An Agreement With Harvest Technologies
  - 11.3.3 Osteotech Enters Into License Agreement With Bacterin International
  - 11.3.4 Osteotech Enters Into License Agreement With Rutgers
  - 11.3.5 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement
  - 11.3.6 Osteotech And LifeNet Form Partnership
  - 11.3.7 Osteotech Terminates Its Distribution Agreement With SpineVision
12 Recent Developments
- 12.1 Product Announcements
  - 12.1.1 Apr 28, 2008 Osteotech, Inc. Plexur P Receives FDA Clearance As Bone Void Filler And Bone Graft Extender In Spine
  - 12.1.2 Mar 04, 2008 Osteotech Receives FDA Clearance for Plexur M Biocomposite
  - 12.1.3 Apr 30, 2008: Osteotech Signs Distribution Agreement With BioHorizons
  - 12.1.4 Apr 18, 2008: Osteotech Renew Tissue Recovery Agreement With EATA
- 12.2 Financial Announcements
  - 12.2.1 May 01, 2008: Osteotech Reports Q1 2008 Results
  - 12.2.2 Apr 17, 2008: Osteotech To Declare Q1 2008 Results
  - 12.2.3 Feb 20, 2008: Osteotech Reports Q4 2007 Results
  - 12.2.4 Feb 15, 2008: Osteotech To Declare Q4 2007 Results
  - 12.2.5 Nov 06, 2007: Osteotech Reports Q3 2007 Results
  - 12.2.6 Aug 01, 2007: Osteotech Declares Q2 2007 Results
  - 12.2.7 May 09, 2007: Osteotech Declares Q1 2007 Results
  - 12.2.8 Mar 08, 2007: Osteotech Declares Q4 2006 Results
- 12.3 Other Significant Developments
  - 12.3.1 Apr 11, 2007: Osteotech Appoints New Board Member
  - 12.3.2 Aug 21, 2006: Osteotech Appoints New Board Member
13 Appendix
- 13.1 Methodology
  - 13.1.1 Coverage
  - 13.1.2 Secondary Research
  - 13.1.3 Primary Research
  - 13.1.4 Expert Panel Validation
- 13.2 Contact Us
- 13.3 About Global Markets Direct
- 13.4 Disclaimer
List of Tables
- Table 1: Osteotech, Inc.,Key Facts
- Table 2: Osteotech, Inc. Pipeline Products by Equipment Type
- Table 3: Osteotech, Inc. Pipeline Products By Development Stage
- Table 4: Osteotech, Inc. Pipeline Products By Therapy Area
- Table 5: Osteotech, Inc. Pipeline Products By News Summaries
- Table 6: Osteotech, Inc., Key Employees,
List of Figures
- Figure 1: Global Markets Direct Methodology